source
- Takeda wins FDA nod for orexin drug oveporexton, first treatment for narcolepsy type 1 and potential broader usesTakeda received FDA approval for oveporexton (brand Orzeyful), an orexin receptor agonist, marking the first approved therapy that targets the orexin system for narcolepsy type 1. The drug mimics…
- HHS seeks public input on new vaccine recommendation categories under Trump and KennedyA request for information was posted by the Department of Health and Human Services, giving the public a 30‑day window to comment on potential changes to the U.S. vaccine recommendation framework.…